Nuvalent CEO exercises options, sells 30K shares
Nuvalent, Inc. President and CEO James Richard Porter reported an exercise-and-sell transaction involving company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nuvalent, Inc. President and CEO James Richard Porter reported an exercise-and-sell transaction involving company stock. He exercised stock options covering 13,714 shares of Class A Common Stock at an exercise price of $18.93 per share and 16,286 shares at $27.85 per share, acquiring 30,000 shares in total. On the same date, he sold 30,000 shares of Class A Common Stock in open-market transactions at prices reported as $103.21, $103.78, $104.78 and $105.60 per share. According to a footnote, these sales were made pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025. Following the transactions, he directly held 324,879 shares of Nuvalent Class A Common Stock.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 13,714 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 16,286 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 13,714 | $18.93 | $260K |
| Exercise | Class A Common Stock | 16,286 | $27.85 | $454K |
| Sale | Class A Common Stock | 11,354 | $103.21 | $1.17M |
| Sale | Class A Common Stock | 12,425 | $103.78 | $1.29M |
| Sale | Class A Common Stock | 6,121 | $104.78 | $641K |
| Sale | Class A Common Stock | 100 | $105.60 | $11K |
Footnotes (6)
- F1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2025.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.52 to $103.51, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4.
- F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.52 to $104.51, inclusive.
- F4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.52 to $105.48, inclusive.
- F5. The shares underlying this option are fully vested.
- F6. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
Stock Option (Right to Buy financial
weighted average price financial
Class A Common Stock financial
Exercise or conversion of derivative security financial
Sale in open market or private transaction financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Nuvalent (NUVL) CEO James Richard Porter report?
What stock options did the Nuvalent (NUVL) CEO exercise in this transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.